Lifebit is a leader in genomics and health data software, aiming to democratize access to omics data through innovative platforms that allow for comprehensive biomedical research.
Lifebit raised $60 million in a Series B funding round led by Tiger Global Management, focusing on precision medicine and data accessibility.
Investment firm focused on public and private companies in the technology industry.
Lifebit aims to expand its presence in the Asia Pacific region and enhance its collaborations in precision medicine.
Navigating regulatory landscapes
Scaling operations internationally
Expansion into Asia Pacific
Collaborations with healthcare organizations and research institutes
Lifebit expands into Asia Pacific and Japan with a new R&D centre in Singapore, partnering with Synapxe to advance precision medicine initiatives.
Lifebit opens an R&D centre in Singapore collaborating with Synapxe to support vital precision medicine research.
Dr. Maria C. Dunford
Pablo Prieto Barja, PhD
Lifebit is a leader in genomics and health data software, aiming to democratize access to omics data through innovative platforms that allow for comprehensive biomedical research.
$60 Million
2022-01-01
Tiger Global Management
Navigating regulatory landscapes Scaling operations internationally
Expansion into Asia Pacific Collaborations with healthcare organizations and research institutes
Lifebit expands into Asia Pacific and Japan with a new R&D centre in Singapore, partnering with Synapxe to advance precision medicine initiatives. Lifebit opens an R&D centre in Singapore collaborating with Synapxe to support vital precision medicine research.
